Chemical Biology and Drug Design

NOVEMBER 10, 2024

Combined with network pharmacology and experimental verification, this study found that platycodin D and luteolin in Jiegeng ( Platycodonis Radix ) may regulate inflammation through the IL-17 signaling pathway to treat influenza virus pneumonia. ABSTRACT This study aimed to explore the pathogenesis of platycodin D and luteolin, which are both active components in Jiegeng ( Platycodonis Radix ), in the treatment of influenza virus pneumonia through network pharmacology analysis combined with expe

Virus 100

Virus Treatment Regulations Disease 100

FDA Law Blog: Drug Discovery

NOVEMBER 10, 2024

By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.

Clinical Development 69

Clinical Development Production Clinical Trials Treatment 69

Covalent Modifiers

NOVEMBER 10, 2024

Gregory B. Craven, Hang Chu, Jessica D. Sun, Jordan D. Carelli, Brittany Coyne, Hao Chen, Ying Chen, Xiaolei Ma, Subhamoy Das, Wayne Kong, Adam D. Zajdlik, Kin S. Yang, Solomon H. Reisberg, Peter A. Thompson, J. Russell Lipford & Jack Taunton Nature, 2024 [link] Somatic alterations in the oncogenic kinase AKT1 have been identified in a broad spectrum of solid tumours.

64

64

Perficient: Drug Development

NOVEMBER 10, 2024

Imagine a busy call center where customer support agents are helping customers resolve issues, answer questions, and provide product guidance. But instead of switching between multiple systems, agents have everything they need in one place: customer information, order history, communication tools, and real-time updates. This is made possible by Salesforce Agentforce , a platform designed to streamline customer service, boost efficiency, and create a better experience for both agents and customer

Production 52

Production 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Patent Watch

NOVEMBER 10, 2024

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … Source

Drugs 52

Drugs 52

Perficient: Drug Development

NOVEMBER 10, 2024

One of the fundamental principles of universal design in healthcare is ensuring clear and simple communication. For individuals with cognitive disabilities, this principle is crucial as it helps them understand and engage with their healthcare more effectively. Here’s how healthcare providers can implement clear and simple communication: The Importance of Clear and Simple Communication Individuals with cognitive disabilities often face challenges in processing complex information.

Treatment 52

Treatment 52